Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Hammer

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Journal of Bacteriology|December 1, 2020
The Two TpsB-Like Proteins in <i>Anabaena</i> sp. Strain PCC 7120 Are Involved in Secretion of Selected SubstratesGiang Ngo, Melis Girbas, Hannah Schätzle, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 15, 2020
Long-term prognosis of de novo atrial fibrillation during acute myocardial infarction: the impact of anti-thrombotic treatment strategiesFelix Hofer, Niema Kazem, Andreas Hammer, et al.
European Cardiology|January 15, 2020
Expert Opinion: Meditation and Cardiovascular Health: What is the Link?Sebastian Schnaubelt, Andreas Hammer, Lorenz Koller, et al.
European Heart Journal Open|August 3, 2022
The age-specific prognostic impact of the platelet-to-lymphocyte ratio on long-term outcome after acute coronary syndromeNiema Kazem, Felix Hofer, Lorenz Koller, et al.
Journal of Clinical Medicine|August 29, 2024
Adherence to Secondary Prevention Measures after Acute Myocardial Infarction and Its Impact on Patient Outcome-A Nationwide PerspectiveAndreas Hammer, Hana Sinkovec, Marko Todorovic, et al.
Journal of Personalized Medicine|July 27, 2022
Cardiogenic Shock Does Not Portend Poor Long-Term Survival in Patients Undergoing Primary Percutaneous Coronary InterventionEva Steinacher, Felix Hofer, Niema Kazem, et al.
Cardiovascular Drugs and Therapy|March 5, 2021
Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Patients with Coronary Artery DiseaseFelix Hofer, Niema Kazem, Ronny Schweitzer, et al.
Mediators of Inflammation|February 28, 2020
The Prognostic Impact of Circulating Regulatory T Lymphocytes on Mortality in Patients with Ischemic Heart Failure with Reduced Ejection FractionAndreas Hammer, Patrick Sulzgruber, Lorenz Koller, et al.
Thrombosis and Haemostasis|November 12, 2021
The Prognostic Potential of Growth Differentiation Factor-15 on Bleeding Events and Patient Outcome after Cardiac Surgery-A Prospective Cohort StudyNiema Kazem, Andreas Hammer, Lorenz Koller, et al.
Cardiovascular Drugs and Therapy|August 3, 2021
Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors and Cardiovascular Outcomes in Patients with Diabetes Mellitus and Heart FailureFelix Hofer, Niema Kazem, Bernhard Richter, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Journal of Bacteriology|December 1, 2020
The Two TpsB-Like Proteins in <i>Anabaena</i> sp. Strain PCC 7120 Are Involved in Secretion of Selected SubstratesGiang Ngo, Melis Girbas, Hannah Schätzle, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 15, 2020
Long-term prognosis of de novo atrial fibrillation during acute myocardial infarction: the impact of anti-thrombotic treatment strategiesFelix Hofer, Niema Kazem, Andreas Hammer, et al.
European Cardiology|January 15, 2020
Expert Opinion: Meditation and Cardiovascular Health: What is the Link?Sebastian Schnaubelt, Andreas Hammer, Lorenz Koller, et al.
European Heart Journal Open|August 3, 2022
The age-specific prognostic impact of the platelet-to-lymphocyte ratio on long-term outcome after acute coronary syndromeNiema Kazem, Felix Hofer, Lorenz Koller, et al.
Journal of Clinical Medicine|August 29, 2024
Adherence to Secondary Prevention Measures after Acute Myocardial Infarction and Its Impact on Patient Outcome-A Nationwide PerspectiveAndreas Hammer, Hana Sinkovec, Marko Todorovic, et al.
Journal of Personalized Medicine|July 27, 2022
Cardiogenic Shock Does Not Portend Poor Long-Term Survival in Patients Undergoing Primary Percutaneous Coronary InterventionEva Steinacher, Felix Hofer, Niema Kazem, et al.
Cardiovascular Drugs and Therapy|March 5, 2021
Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Patients with Coronary Artery DiseaseFelix Hofer, Niema Kazem, Ronny Schweitzer, et al.
Mediators of Inflammation|February 28, 2020
The Prognostic Impact of Circulating Regulatory T Lymphocytes on Mortality in Patients with Ischemic Heart Failure with Reduced Ejection FractionAndreas Hammer, Patrick Sulzgruber, Lorenz Koller, et al.
Thrombosis and Haemostasis|November 12, 2021
The Prognostic Potential of Growth Differentiation Factor-15 on Bleeding Events and Patient Outcome after Cardiac Surgery-A Prospective Cohort StudyNiema Kazem, Andreas Hammer, Lorenz Koller, et al.
Cardiovascular Drugs and Therapy|August 3, 2021
Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors and Cardiovascular Outcomes in Patients with Diabetes Mellitus and Heart FailureFelix Hofer, Niema Kazem, Bernhard Richter, et al.
Pageof 4